Cargando…
BAFF Inhibition Effectively Suppresses the Development of Anti-HLA.A2 Antibody in the Highly Sensitized Mouse Model
B cell activating factor (BAFF) is a cytokine that plays a role in the survival, proliferation and differentiation of B cells. We proposed to observe the effects of BAFF inhibition on the humoral immune responses of an allosensitized mouse model using HLA.A2 transgenic mice. Wild-type C57BL/6 mice w...
Autores principales: | Min, Ji Won, Shin, Yoo-Jin, Lee, Hyeyoung, Kim, Bo-Mi, Park, Ki Hyun, Doh, Kyoung Chan, Kim, Tae-Min, Lim, Sun Woo, Yang, Chul Woo, Oh, Eun-Jee, Chung, Byung Ha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830620/ https://www.ncbi.nlm.nih.gov/pubmed/33467096 http://dx.doi.org/10.3390/ijms22020861 |
Ejemplares similares
-
Clinical Significance of Pre- and Post-Transplant BAFF Levels in Kidney Transplant Recipients
por: Min, Ji Won, et al.
Publicado: (2016) -
Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2016) -
Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2018) -
Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2022) -
Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients
por: Lee, Haeun, et al.
Publicado: (2023)